(ORCL) Oracle - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US68389X1054
Stock: Cloud Software, Databases, Infrastructure, Hardware
Total Rating 33
Risk 76
Buy Signal -1.12
| Risk 5d forecast | |
|---|---|
| Volatility | 59.4% |
| Relative Tail Risk | -14.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.26 |
| Alpha | -29.87 |
| Character TTM | |
|---|---|
| Beta | 1.702 |
| Beta Downside | 1.529 |
| Drawdowns 3y | |
|---|---|
| Max DD | 58.25% |
| CAGR/Max DD | 0.41 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
volatile
Description: ORCL Oracle March 04, 2026
Oracle Corporation provides enterprise IT products and services globally. Key offerings include cloud-based software as a service (SaaS) applications for ERP, EPM, SCM, and HCM. SaaS is a rapidly growing segment within the software industry, offering subscription-based access to applications over the internet.
The company also offers cloud and on-premise licenses for its database technologies, such as Oracle Database and MySQL, and infrastructure technologies, including compute, storage, and networking. Oracles business model combines recurring revenue from cloud subscriptions and support services with traditional software licensing.
Additionally, Oracle provides hardware products like engineered systems and servers, along with related support and consulting services. These products cater to various industries, government agencies, and educational institutions through direct and indirect sales channels.
For more detailed financial analysis, consider exploring ValueRays comprehensive reports.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 15.43b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.06 > 0.02 and ΔFCF/TA -12.86 > 1.0 |
| NWC/Revenue: -5.62% < 20% (prev -10.10%; Δ 4.48% < -1%) |
| CFO/TA 0.11 > 3% & CFO 22.30b > Net Income 15.43b |
| Net Debt (105.14b) to EBITDA (27.00b): 3.89 < 3 |
| Current Ratio: 0.91 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.92b) vs 12m ago 1.85% < -2% |
| Gross Margin: 68.54% > 18% (prev 0.71%; Δ 6783 % > 0.5%) |
| Asset Turnover: 34.52% > 50% (prev 37.00%; Δ -2.47% > 0%) |
| Interest Coverage Ratio: 5.51 > 6 (EBITDA TTM 27.00b / Interest Expense TTM 3.85b) |
Altman Z'' 0.73
| A: -0.02 (Total Current Assets 34.37b - Total Current Liabilities 37.80b) / Total Assets 204.98b |
| B: -0.05 (Retained Earnings -9.36b / Total Assets 204.98b) |
| C: 0.12 (EBIT TTM 21.22b / Avg Total Assets 176.73b) |
| D: 0.17 (Book Value of Equity 29.95b / Total Liabilities 174.53b) |
| Altman-Z'' Score: 0.73 = B |
Beneish M -3.06
| DSRI: 1.04 (Receivables 9.44b/8.18b, Revenue 61.02b/54.93b) |
| GMI: 1.04 (GM 68.54% / 71.27%) |
| AQI: 0.76 (AQ_t 0.50 / AQ_t-1 0.66) |
| SGI: 1.11 (Revenue 61.02b / 54.93b) |
| TATA: -0.03 (NI 15.43b - CFO 22.30b) / TA 204.98b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of ORCL shares?
As of March 08, 2026, the stock is trading at USD 152.96 with a total of 37,683,807 shares traded.
Over the past week, the price has changed by +5.20%, over one month by +7.10%, over three months by -30.46% and over the past year by +2.37%.
Over the past week, the price has changed by +5.20%, over one month by +7.10%, over three months by -30.46% and over the past year by +2.37%.
Is ORCL a buy, sell or hold?
Oracle has received a consensus analysts rating of 4.13.
Therefore, it is recommended to buy ORCL.
- StrongBuy: 20
- Buy: 4
- Hold: 15
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ORCL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 269.9 | 76.5% |
| Analysts Target Price | 269.9 | 76.5% |
ORCL Fundamental Data Overview March 06, 2026
P/E Trailing = 28.641
P/E Forward = 18.622
P/S = 7.1772
P/B = 14.299
P/EG = 1.1715
Revenue TTM = 61.02b USD
EBIT TTM = 21.22b USD
EBITDA TTM = 27.00b USD
Long Term Debt = 99.98b USD (from longTermDebt, last quarter)
Short Term Debt = 8.09b USD (from shortTermDebt, last quarter)
Debt = 124.39b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 105.14b USD (from netDebt column, last quarter)
Enterprise Value = 542.55b USD (437.93b + Debt 124.39b - CCE 19.77b)
Interest Coverage Ratio = 5.51 (Ebit TTM 21.22b / Interest Expense TTM 3.85b)
EV/FCF = -41.16x (Enterprise Value 542.55b / FCF TTM -13.18b)
FCF Yield = -2.43% (FCF TTM -13.18b / Enterprise Value 542.55b)
FCF Margin = -21.60% (FCF TTM -13.18b / Revenue TTM 61.02b)
Net Margin = 25.28% (Net Income TTM 15.43b / Revenue TTM 61.02b)
Gross Margin = 68.54% ((Revenue TTM 61.02b - Cost of Revenue TTM 19.19b) / Revenue TTM)
Gross Margin QoQ = 66.53% (prev 67.28%)
Tobins Q-Ratio = 2.65 (Enterprise Value 542.55b / Total Assets 204.98b)
Interest Expense / Debt = 0.85% (Interest Expense 1.06b / Debt 124.39b)
Taxrate = 3.26% (207.0m / 6.34b)
NOPAT = 20.53b (EBIT 21.22b * (1 - 3.26%))
Current Ratio = 0.91 (Total Current Assets 34.37b / Total Current Liabilities 37.80b)
Debt / Equity = 4.15 (Debt 124.39b / totalStockholderEquity, last quarter 29.95b)
Debt / EBITDA = 3.89 (Net Debt 105.14b / EBITDA 27.00b)
Debt / FCF = -7.98 (negative FCF - burning cash) (Net Debt 105.14b / FCF TTM -13.18b)
Total Stockholder Equity = 22.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.73% (Net Income 15.43b / Total Assets 204.98b)
RoE = 67.59% (Net Income TTM 15.43b / Total Stockholder Equity 22.82b)
RoCE = 17.28% (EBIT 21.22b / Capital Employed (Equity 22.82b + L.T.Debt 99.98b))
RoIC = 17.12% (NOPAT 20.53b / Invested Capital 119.88b)
WACC = 9.68% (E(437.93b)/V(562.31b) * Re(12.19%) + D(124.39b)/V(562.31b) * Rd(0.85%) * (1-Tc(0.03)))
Discount Rate = 12.19% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.85%
[DCF] Fair Price = unknown (Cash Flow -13.18b)
EPS Correlation: 63.90 | EPS CAGR: 20.30% | SUE: 4.0 | # QB: 1
Revenue Correlation: 92.75 | Revenue CAGR: 11.96% | SUE: -0.38 | # QB: 0
EPS current Year (2026-05-31): EPS=7.34 | Chg7d=-0.006 | Chg30d=-0.014 | Revisions Net=-3 | Growth EPS=+21.8% | Growth Revenue=+16.6%
EPS next Year (2027-05-31): EPS=7.93 | Chg7d=+0.029 | Chg30d=-0.008 | Revisions Net=-2 | Growth EPS=+8.0% | Growth Revenue=+29.0%
[Analyst] Revisions Ratio: -0.60 (1 Up / 4 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 8.7% (Discount Rate 12.2% - Earnings Yield 3.5%)
[Growth] Growth Spread = +20.3% (Analyst 29.0% - Implied 8.7%)
P/E Forward = 18.622
P/S = 7.1772
P/B = 14.299
P/EG = 1.1715
Revenue TTM = 61.02b USD
EBIT TTM = 21.22b USD
EBITDA TTM = 27.00b USD
Long Term Debt = 99.98b USD (from longTermDebt, last quarter)
Short Term Debt = 8.09b USD (from shortTermDebt, last quarter)
Debt = 124.39b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 105.14b USD (from netDebt column, last quarter)
Enterprise Value = 542.55b USD (437.93b + Debt 124.39b - CCE 19.77b)
Interest Coverage Ratio = 5.51 (Ebit TTM 21.22b / Interest Expense TTM 3.85b)
EV/FCF = -41.16x (Enterprise Value 542.55b / FCF TTM -13.18b)
FCF Yield = -2.43% (FCF TTM -13.18b / Enterprise Value 542.55b)
FCF Margin = -21.60% (FCF TTM -13.18b / Revenue TTM 61.02b)
Net Margin = 25.28% (Net Income TTM 15.43b / Revenue TTM 61.02b)
Gross Margin = 68.54% ((Revenue TTM 61.02b - Cost of Revenue TTM 19.19b) / Revenue TTM)
Gross Margin QoQ = 66.53% (prev 67.28%)
Tobins Q-Ratio = 2.65 (Enterprise Value 542.55b / Total Assets 204.98b)
Interest Expense / Debt = 0.85% (Interest Expense 1.06b / Debt 124.39b)
Taxrate = 3.26% (207.0m / 6.34b)
NOPAT = 20.53b (EBIT 21.22b * (1 - 3.26%))
Current Ratio = 0.91 (Total Current Assets 34.37b / Total Current Liabilities 37.80b)
Debt / Equity = 4.15 (Debt 124.39b / totalStockholderEquity, last quarter 29.95b)
Debt / EBITDA = 3.89 (Net Debt 105.14b / EBITDA 27.00b)
Debt / FCF = -7.98 (negative FCF - burning cash) (Net Debt 105.14b / FCF TTM -13.18b)
Total Stockholder Equity = 22.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.73% (Net Income 15.43b / Total Assets 204.98b)
RoE = 67.59% (Net Income TTM 15.43b / Total Stockholder Equity 22.82b)
RoCE = 17.28% (EBIT 21.22b / Capital Employed (Equity 22.82b + L.T.Debt 99.98b))
RoIC = 17.12% (NOPAT 20.53b / Invested Capital 119.88b)
WACC = 9.68% (E(437.93b)/V(562.31b) * Re(12.19%) + D(124.39b)/V(562.31b) * Rd(0.85%) * (1-Tc(0.03)))
Discount Rate = 12.19% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.85%
[DCF] Fair Price = unknown (Cash Flow -13.18b)
EPS Correlation: 63.90 | EPS CAGR: 20.30% | SUE: 4.0 | # QB: 1
Revenue Correlation: 92.75 | Revenue CAGR: 11.96% | SUE: -0.38 | # QB: 0
EPS current Year (2026-05-31): EPS=7.34 | Chg7d=-0.006 | Chg30d=-0.014 | Revisions Net=-3 | Growth EPS=+21.8% | Growth Revenue=+16.6%
EPS next Year (2027-05-31): EPS=7.93 | Chg7d=+0.029 | Chg30d=-0.008 | Revisions Net=-2 | Growth EPS=+8.0% | Growth Revenue=+29.0%
[Analyst] Revisions Ratio: -0.60 (1 Up / 4 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 8.7% (Discount Rate 12.2% - Earnings Yield 3.5%)
[Growth] Growth Spread = +20.3% (Analyst 29.0% - Implied 8.7%)